For adults in Tampa researching weight management options, Tirzepatide is the active pharmaceutical ingredient in the FDA-approved products Mounjaro / Zepbound, which were studied in trials supporting their FDA approvals. With Florida reporting an obesity rate of 32.4% and diabetes affecting 12.1% of the population, demand for medically supervised GLP-1 care in the Southeast continues to grow. Weight Method's separate program prescribes compounded Tirzepatide (dispensed by U.S.-licensed 503A pharmacies and not FDA-approved) to Tampa residents through telehealth — no clinic visit required.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Tampa is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Tampa, FL. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
For many people in Tampa, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide (Mounjaro / Zepbound) addresses the hormonal drivers of excess weight, helping your body regulate appetite at the source. Weight Method's telehealth program brings this treatment to Florida residents with a streamlined process: complete an online assessment, consult with a licensed provider, and receive your Tirzepatide shipped directly to your Tampa address. Average weight loss in clinical trials is 20-25% of body weight of body weight over 12-18 months.
Hispanic adults in Tampa face disproportionately high rates of obesity and type 2 diabetes, conditions that Tirzepatide is specifically designed to treat. Weight Method removes the barriers that have historically limited access — language, cost, and insurance requirements. Our platform is fully bilingual, Tirzepatide starts at $329/month with no insurance needed, and everything happens virtually from your Tampa home.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Florida and start Tirzepatide from $329/month.
Get Started NowFree consultation. No commitment.